DFTX FY 2021 Earnings — Definium Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DFTXDefinium Therapeutics, Inc.

$2B

FY 2021 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$94M

Net Income

-$93M

EPS (Diluted)

$-3.40

Cash Flow

Operating Cash Flow

-$46M

Free Cash Flow

-$46M

Stock-Based Comp.

$43M

Balance Sheet

Total Assets

$164M

Total Liabilities

$12M

Stockholders' Equity

$152M

Cash & Equivalents

$134M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$94M	-$33M	-184.1%
Net Income	-$93M	-$34M	-172.8%